Blue Earth Diagnostics to Showcase Advancements in Molecular Imaging at SNMMI 2026 Annual Meeting#United_States#Los_Angeles,_CA#PET_imaging#Blue_Earth_Diagnostics#PSA_Levels
Blue Earth Diagnostics to Showcase Advancements in Molecular Imaging at SNMMI 2026 Annual Meeting
Explore how Blue Earth Diagnostics is pushing the boundaries of molecular imaging at the upcoming SNMMI 2026 Annual Meeting with groundbreaking data.
third-news.com
May 19, 2026 at 11:27 AM
Blue Earth Diagnostics to Showcase Advancements in Molecular Imaging at SNMMI 2026 Annual Meeting#United_States#Los_Angeles,_CA#PET_imaging#Blue_Earth_Diagnostics#PSA_Levels
Medical Cyclotron Market Growth: Projected to Hit $405.4 Million by 2033#None#Nuclear_Medicine#PET_imaging#Medical_Cyclotron
Medical Cyclotron Market Growth: Projected to Hit $405.4 Million by 2033
The medical cyclotron market is set to grow significantly, projected to reach $405.4 million by 2033 driven by advancements in diagnostics.
third-news.com
February 24, 2026 at 4:34 PM
Medical Cyclotron Market Growth: Projected to Hit $405.4 Million by 2033#None#Nuclear_Medicine#PET_imaging#Medical_Cyclotron
Nuclear Medicine Market Expected to Reach $21.01 Billion by 2030, Shows Steady Growth#None#radiopharmaceuticals#Nuclear_Medicine#PET_imaging
Nuclear Medicine Market Expected to Reach $21.01 Billion by 2030, Shows Steady Growth
The nuclear medicine market is forecasted to increase from $10.41 billion in 2025 to $21.01 billion by 2030, driven by advancements in diagnostic technologies and radiopharmaceuticals.
third-news.com
January 26, 2026 at 12:12 PM
Nuclear Medicine Market Expected to Reach $21.01 Billion by 2030, Shows Steady Growth#None#radiopharmaceuticals#Nuclear_Medicine#PET_imaging
Innovative Development of Theranostic PET Imaging Agents by Okayama University Revolutionizes Diagnosis and Treatment#Japan#Theranostics#Okayama#Okayama_University#PET_imaging
Innovative Development of Theranostic PET Imaging Agents by Okayama University Revolutionizes Diagnosis and Treatment
Okayama University is pioneering new PET imaging agents that enhance diagnosis and treatment effectiveness for various diseases, including cancer and neurological disorders.
third-news.com
August 28, 2025 at 5:07 PM
Innovative Development of Theranostic PET Imaging Agents by Okayama University Revolutionizes Diagnosis and Treatment#Japan#Theranostics#Okayama#Okayama_University#PET_imaging
GE Healthcare Japan Expands Insurance Coverage for Alzheimer’s PET Imaging with Vizamyl#Japan#GE_HealthCare#Hino_City#PET_imaging#Vizamyl
GE Healthcare Japan Expands Insurance Coverage for Alzheimer’s PET Imaging with Vizamyl
GE Healthcare Japan announces the expansion of insurance coverage for Vizamyl, facilitating early Alzheimer's diagnosis through advanced PET imaging.
third-news.com
June 9, 2025 at 1:55 AM
GE Healthcare Japan Expands Insurance Coverage for Alzheimer’s PET Imaging with Vizamyl#Japan#GE_HealthCare#Hino_City#PET_imaging#Vizamyl
Life Molecular Imaging Receives Funding to Study Alzheimer’s Neuroinflammation with PET Technology#United_States#Boston#Life_Molecular_Imaging#Alzheimer’s_Drug_Discovery_Foundation#PET_imaging
Life Molecular Imaging Receives Funding to Study Alzheimer’s Neuroinflammation with PET Technology
Life Molecular Imaging has secured $2.16 million from the Alzheimer's Drug Discovery Foundation to enhance PET imaging research for Alzheimer’s disease neuroinflammation over three years.
third-news.com
May 20, 2025 at 1:05 PM
Life Molecular Imaging Receives Funding to Study Alzheimer’s Neuroinflammation with PET Technology#United_States#Boston#Life_Molecular_Imaging#Alzheimer’s_Drug_Discovery_Foundation#PET_imaging
Illuccix® Gains Approval in the UK: A Breakthrough for Prostate Cancer Detection#United_Kingdom#N/A#Telix_Pharmaceuticals#Illuccix#PSMA-PET_Imaging
Illuccix® Gains Approval in the UK: A Breakthrough for Prostate Cancer Detection
Telix Pharmaceuticals has received approval for Illuccix®, enhancing prostate cancer imaging in the UK, addressing urgent patient needs.
third-news.com
February 12, 2025 at 9:45 PM
Illuccix® Gains Approval in the UK: A Breakthrough for Prostate Cancer Detection#United_Kingdom#N/A#Telix_Pharmaceuticals#Illuccix#PSMA-PET_Imaging